JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
Change in Working Capital
JW (Cayman) Therapeutics Co Ltd
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Change in Working Capital
¥36.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
110%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Change in Working Capital
-¥12.8B
|
CAGR 3-Years
-278%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Change in Working Capital
¥517.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Change in Working Capital
-¥3.9B
|
CAGR 3-Years
-70%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Change in Working Capital
-¥3.6B
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-32%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Change in Working Capital
-¥380.3m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Change in Working Capital?
Change in Working Capital
36.9m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Change in Working Capital amounts to 36.9m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
110%
The average annual Change in Working Capital growth rates for JW (Cayman) Therapeutics Co Ltd have been 22% over the past three years , 110% over the past five years .